Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 50.50M | 51.08M | 43.90M | 55.48M | 47.20M | 56.76M |
Gross Profit | 17.85M | 19.93M | 15.42M | 24.41M | 15.09M | 15.64M |
EBITDA | -4.12M | 11.70M | 12.70M | 18.69M | 18.38M | 17.52M |
Net Income | -10.78M | -10.51M | -9.46M | -3.05M | -4.69M | -5.69M |
Balance Sheet | ||||||
Total Assets | 54.17M | 66.16M | 90.63M | 85.66M | 97.07M | 105.07M |
Cash, Cash Equivalents and Short-Term Investments | 28.28M | 31.87M | 34.40M | 38.48M | 46.01M | 54.94M |
Total Debt | 20.52M | 26.63M | 41.26M | 28.41M | 34.20M | 35.76M |
Total Liabilities | 29.41M | 36.09M | 50.05M | 35.62M | 44.33M | 47.20M |
Stockholders Equity | 24.76M | 30.07M | 40.58M | 50.04M | 53.05M | 57.74M |
Cash Flow | ||||||
Free Cash Flow | 13.68M | 18.86M | 17.23M | 18.66M | 5.36M | 12.15M |
Operating Cash Flow | 14.56M | 19.75M | 17.49M | 18.99M | 7.50M | 13.97M |
Investing Cash Flow | 5.02M | 21.51M | -10.61M | -3.79M | -12.20M | 388.00K |
Financing Cash Flow | -21.61M | -21.87M | -21.66M | -21.13M | -21.53M | -21.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | 5.89B | 18.71 | 25.23% | 3.45% | -2.95% | 56.65% | |
56 Neutral | HK$17.01M | 9.88 | -3.24% | ― | 38.94% | -71.65% | |
56 Neutral | HK$161.63M | 8.38 | 38.36% | ― | -71.92% | ― | |
52 Neutral | HK$15.84M | ― | -41.73% | ― | 13.37% | -4.90% | |
45 Neutral | HK$17.28M | ― | -19.55% | ― | 70.28% | -16.20% | |
44 Neutral | HK$14.47M | ― | -33.77% | ― | -3.25% | 89.16% | |
31 Underperform | HK$19.51M | ― | -1039.35% | ― | -11.50% | 81.10% |